High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users
High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users
复制标题
DOI：
10.1080/00952990701312316
复制
发表时间：
2007-01-01
影响因子：
2.7
通讯作者：
Blanc, Paul D.
中科院分区：
文献类型：
--
作者：
Kim, Susan Y.;Anderson, Ilene B.;Blanc, Paul D.
简介：对与γ-羟基丁酸（GHB）发病率有关的行为知之甚少。研究方法：我们调查了131 GHB用户，使用逻辑回归来测试高风险行为和GHB医院治疗之间的关联（26 [20%]的受试者）。结果如下：GHB住院治疗的风险增加与以下因素有关：同时摄入乙醇（OR 5.2; 95% CI 1.7-16），在GHB影响下驾驶（OR 3.2; 95%，CI 1.3-7.8）、使用GHB治疗戒断症状（OR 2.9; 95% CI 1.1-7.9）和同时摄入氯胺酮（OR 2.7; 95% CI 1.1-6.7）。结论：有针对性的预防活动可以集中在选定的高危行为。
Introduction: Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity. Methods: We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects). Results: Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8), use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7). Conclusion: Targeted prevention activities could focus on selected high-risk behaviors.